Skip to content
Elicio
Contact
Careers
In the News
Elicio in the News
LinkedIn
Twitter
About
Company Overview
Management Team
Board of Directors
Amphiphile Technology
Lymphatic System Primer
The AMP Platform
Publications
Pipeline & Programs
Pipeline
ELI-002
ELI-004
Other Preclinical Programs
Investors
Overview
News & Events
Stock Information
Corporate Governance
Financial & Filings
IR Resources
Careers
Contact
Elicio in the News
News
June 1, 2023 ||
Elicio Therapeutics Announces Completion of Merger with Angion Biomedica
Post navigation
Elicio Therapeutics to Present Interim Data from the Ongoing Phase 1 Study of Investigational Therapeutic Cancer Vaccine, ELI-002, in Patients with High Relapse Risk Pancreatic and Colorectal Cancer at ASCO
Elicio Merges With Angion to Support Mutant KRAS-Targeted Cancer Vaccine Development
